Ravina Kullar

4.0k total citations
71 papers, 2.8k citations indexed

About

Ravina Kullar is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Ravina Kullar has authored 71 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 29 papers in Epidemiology and 25 papers in Clinical Biochemistry. Recurrent topics in Ravina Kullar's work include Bacterial Identification and Susceptibility Testing (25 papers), Antimicrobial Resistance in Staphylococcus (24 papers) and Antibiotic Use and Resistance (16 papers). Ravina Kullar is often cited by papers focused on Bacterial Identification and Susceptibility Testing (25 papers), Antimicrobial Resistance in Staphylococcus (24 papers) and Antibiotic Use and Resistance (16 papers). Ravina Kullar collaborates with scholars based in United States, United Kingdom and Australia. Ravina Kullar's co-authors include Michael J. Rybak, Susan L. Davis, Donald P. Levine, George Sakoulas, Debra A. Goff, Ellie J. C. Goldstein, Keith S. Kaye, Lucas Schulz, Warren E. Rose and Jing Zhao and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ravina Kullar

71 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ravina Kullar United States	29	1.6k	990	797	715	459	71	2.8k
P. Brandon Bookstaver United States	30	733 0.5×	631 0.6×	902 1.1×	733 1.0×	647 1.4×	171	3.1k
James A. McKinnell United States	27	1.3k 0.8×	480 0.5×	806 1.0×	278 0.4×	333 0.7×	81	2.5k
Kerri A. Thom United States	31	1.2k 0.8×	491 0.5×	678 0.9×	322 0.5×	559 1.2×	92	3.1k
Thomas Bischoff Switzerland	13	2.3k 1.4×	815 0.8×	1.7k 2.1×	304 0.4×	481 1.0×	47	4.0k
A.P.R. Wilson United Kingdom	28	1.2k 0.7×	500 0.5×	614 0.8×	394 0.6×	418 0.9×	78	2.5k
Debra A. Goff United States	36	1.1k 0.7×	1.1k 1.1×	990 1.2×	735 1.0×	1.4k 3.0×	114	3.6k
Graeme N. Forrest United States	32	2.0k 1.3×	779 0.8×	1.9k 2.3×	225 0.3×	575 1.3×	80	3.5k
Giulia De Angelis Italy	32	1.2k 0.8×	862 0.9×	989 1.2×	330 0.5×	807 1.8×	106	3.4k
Mandy Wootton United Kingdom	28	1.2k 0.8×	940 0.9×	986 1.2×	419 0.6×	246 0.5×	92	2.8k
Martin E. Evans United States	27	1.1k 0.7×	466 0.5×	779 1.0×	582 0.8×	449 1.0×	96	3.0k

Countries citing papers authored by Ravina Kullar

Since Specialization

Citations

This map shows the geographic impact of Ravina Kullar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravina Kullar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravina Kullar more than expected).

Fields of papers citing papers by Ravina Kullar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravina Kullar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravina Kullar. The network helps show where Ravina Kullar may publish in the future.

Co-authorship network of co-authors of Ravina Kullar

This figure shows the co-authorship network connecting the top 25 collaborators of Ravina Kullar. A scholar is included among the top collaborators of Ravina Kullar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravina Kullar. Ravina Kullar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marcelin, Jasmine R, Rohan Khazanchi, Elizabeth Lyden, et al.. (2025). INSIDE-OUT: Introduction of Speakers at IDWeek Events—Observing for Unconscious Bias Over Time. Open Forum Infectious Diseases. 12(2). ofaf024–ofaf024. 1 indexed citations

Kullar, Ravina, et al.. (2025). Next-Generation Sequencing in Periprosthetic Joint Infections. Infectious Diseases in Clinical Practice. 33(3). 1 indexed citations

Jinks, Timothy, Sumithra Subramaniam, Matteo Bassetti, et al.. (2024). Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals. Infectious Diseases and Therapy. 13(7). 1621–1637. 7 indexed citations

Kullar, Ravina, Ellie J. C. Goldstein, Stuart Johnson, & Lynne V. McFarland. (2023). Lactobacillus Bacteremia and Probiotics: A Review. Microorganisms. 11(4). 896–896. 70 indexed citations

McFarland, Lynne V., Ellie J. C. Goldstein, & Ravina Kullar. (2023). Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections. Microorganisms. 11(6). 1534–1534. 3 indexed citations

Marcelin, Jasmine R, Rohan Khazanchi, Kelly Cawcutt, et al.. (2022). Demographic Representation Among Speakers and Program Committee Members at the IDWeek Conference, 2013–2021. Clinical Infectious Diseases. 76(5). 897–904. 7 indexed citations

Gil, Raul Macias, Tracey Freeman, Trini Mathew, et al.. (2021). Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Communities and the Coronavirus Disease 2019 Pandemic: A Call to Break the Cycle of Structural Barriers. The Journal of Infectious Diseases. 224(11). 1810–1820. 20 indexed citations

Marcelin, Jasmine R, Talia H. Swartz, Vladimir Berthaud, et al.. (2021). Addressing and Inspiring Vaccine Confidence in Black, Indigenous, and People of Color During the Coronavirus Disease 2019 Pandemic. Open Forum Infectious Diseases. 8(9). ofab417–ofab417. 33 indexed citations

Kullar, Ravina, Jasmine R Marcelin, Talia H. Swartz, et al.. (2020). Racial Disparity of Coronavirus Disease 2019 in African American Communities. The Journal of Infectious Diseases. 222(6). 890–893. 84 indexed citations

10.

Kullar, Ravina, Laura Puzniak, Jason Swindle, & Thomas P. Lodise. (2020). Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting. Infectious Diseases and Therapy. 9(1). 107–117. 8 indexed citations

11.

McCreary, Erin K, Ravina Kullar, Matthew Geriak, et al.. (2019). Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments. Open Forum Infectious Diseases. 7(1). ofz538–ofz538. 65 indexed citations

12.

Geriak, Matthew, Fadi Haddad, Warren E. Rose, et al.. (2019). Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrobial Agents and Chemotherapy. 63(5). 138 indexed citations

13.

Ha, David, Rita Drummond Olans, Richard N. Olans, et al.. (2019). A Multidisciplinary Approach to Incorporate Bedside Nurses into Antimicrobial Stewardship and Infection Prevention. The Joint Commission Journal on Quality and Patient Safety. 45(9). 600–605. 29 indexed citations

14.

Goff, Debra A., Ravina Kullar, Karri A. Bauer, & Thomas M. File. (2017). Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals. Clinical Infectious Diseases. 64(8). 1134–1139. 50 indexed citations

15.

Goff, Debra A., Ravina Kullar, Ellie J. C. Goldstein, et al.. (2016). A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. The Lancet Infectious Diseases. 17(2). e56–e63. 162 indexed citations

16.

Kullar, Ravina, George Sakoulas, Stan Deresinski, & Sebastiaan J. van Hal. (2015). When sepsis persists: a review of MRSA bacteraemia salvage therapy. Journal of Antimicrobial Chemotherapy. 71(3). 576–586. 56 indexed citations

17.

Sakoulas, George, Pamela Moise, Anthony M. Casapao, et al.. (2014). Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline. Clinical Therapeutics. 36(10). 1317–1333. 139 indexed citations

18.

Murray, Kyle P., Jing Zhao, Susan L. Davis, et al.. (2013). Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study. Clinical Infectious Diseases. 56(11). 1562–1569. 128 indexed citations

19.

Kullar, Ravina, Steven Leonard, Susan L. Davis, et al.. (2011). Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15–20 mg/L Suggested by the Vancomycin Consensus Guidelines. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(5). 441–448. 91 indexed citations

20.

Kullar, Ravina, Susan L. Davis, Donald P. Levine, & Michael J. Rybak. (2011). Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets. Clinical Infectious Diseases. 52(8). 975–981. 356 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact